Date published: 2025-10-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

HGFL Activators

Hepatocyte Growth Factor-Like protein (HGFL), also known as Macrophage-Stimulating Protein (MSP), is a serum protein produced predominantly by the liver. It plays a significant role in various physiological processes, including tissue regeneration, immune response, and embryonic development.HGFL is a member of the plasminogen-related growth factor family and functions as a ligand for the Ron receptor tyrosine kinase (also known as MST1R). It is synthesized as a single-chain inactive precursor that is cleaved into a biologically active, disulfide-linked two-chain entity. The alpha chain of HGFL binds to the Ron receptor, and the beta chain is responsible for the protein's activation.

Upon binding and activation, HGFL initiates a cascade of intracellular signals leading to various cellular responses. These responses include cell proliferation, motility, survival, and differentiation, which are crucial for tissue repair and regeneration.Interestingly, HGFL and the Ron receptor have been implicated in cancer pathogenesis. Abnormal activation of the Ron receptor by HGFL has been observed in various cancers, leading to tumor growth, invasion, and metastasis. This makes HGFL a potential target for intervention in cancer.Further, HGFL plays a role in immune regulation, with studies showing its involvement in the suppression of inflammatory responses and the promotion of tissue repair during inflammation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

XL-184 free base

849217-68-1sc-364657
sc-364657A
5 mg
10 mg
$92.00
$204.00
1
(1)

Inhibits multiple tyrosine kinases including c-Met, potentially affecting HGFL-related pathways.

Stat3 inhibitor V, stattic

19983-44-9sc-202818
sc-202818A
sc-202818B
sc-202818C
sc-202818D
sc-202818E
sc-202818F
25 mg
100 mg
250 mg
500 mg
1 g
2.5 g
5 g
$127.00
$192.00
$269.00
$502.00
$717.00
$1380.00
$2050.00
114
(3)

Inhibits STAT3, a downstream effector of Ron, thus indirectly influencing HGFL signaling.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

A kinase inhibitor that targets several pathways, potentially affecting HGFL-Ron signaling indirectly.

Lenvatinib

417716-92-8sc-488530
sc-488530A
sc-488530B
5 mg
25 mg
100 mg
$178.00
$648.00
$1657.00
3
(0)

Targets multiple receptor tyrosine kinases, including c-Met, potentially affecting HGFL-related signaling.

INCB28060

1029712-80-8sc-364510
sc-364510A
10 mg
50 mg
$305.00
$750.00
(0)

A selective c-Met inhibitor, might have indirect effects on HGFL signaling pathways.

FK-866

658084-64-1sc-205325
sc-205325A
5 mg
10 mg
$140.00
$245.00
12
(1)

A specific inhibitor of c-Met, can indirectly affect HGFL-Ron signaling.